(3-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol, 98%, 10g

Methyl 4-chloro-3-(hydroxymethyl)benzoate, 98%, 250mg

1-Bromo-2-fluoro-4-methoxy-5-nitrobenzene, 95.0%, 100g

1-METHOXYCYCLOPROPANE-1-CARBOXYLIC ACID, 95.0%, 1g

6-t-Butyl-4-chlorothieno[3,2-d]pyrimidine, 95.0%, 5g

Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-Nomega-(2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl)-L-arginine>98.0%(HPLC)(T)25g

Ethyl 2-(benzo[d]oxazol-2-yl)acetate, 97.0%, 25g

1-(5-Bromo-2-methoxyphenyl)-2,2,2-trifluoroethanone, 250mg

5-(hydroxymethyl)-2-(trifluoromethyl)-Benzoic acid methyl ester, 95%, 100mg

4-Amino-5-bromo-2-methylpyridine, 95.0%, 100g

Kapillarpipetten ringcaps® 1 Marke, 50 µl, 1000 Stück

2-Chloro-N-(2-chloro-4-methyl-3-pyridyl)nicotinamide>98.0%(GC)25g

2,4'-Dimethoxybenzophenone>98.0%(GC)5g